Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mouse Anti-Monkeypox Virus L1R Monoclonal Antibody

Cat. No.VD7N123

Product TypeVeterinary Antibodies

Size

Product Overview

BioVenic mouse monoclonal antibody is specific for monkeypox L1R. It is affinity purified by protein G. It can be applied to ELISA and WB of monkeypox L1R.

Specifications

Application ELISA; WB
Clonality Monoclonal
Classification Primary Antibody
Clone L13N5
Host Mouse
Target Species Virus
Species Reactivity Virus
Specificity Monkeypox L1R Protein
Immunogen Recombinant monkeypox L1R protein
Purification Protein G Purified
Purity > 90%
Conjugation Unconjugated
Preservative and Stabilizer 0.05% Sodium Azide
Buffer Phosphate Buffered Saline with 0.05% Bovine Serum Albumin
Physical State Liquid

Target Information

The L1R protein is involved in the assembly and release of the virus from infected cells. It is a component of the intracellular mature virus (IMV) form of the virus, which is crucial for its replication cycle. L1R is an immunogenic protein that can elicit a strong immune response in the host. It has been identified as a target for neutralizing antibodies, which can prevent the spread of the virus within the host.

Target Monkeypox L1R Protein
Taxonomy ID 10244
Gene ID 928968
UniProt ID Q3I7N2

Shipping and Storage

This product is shipped with ice gel packs. Store at -20°C (up to 12 months) on receipt. Avoid repeated freezing and thawing as this may denature the antibody.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Li, Yanjiao, et al. "Monkeypox virus 2022, gene heterogeneity and protein polymorphism." Signal transduction and targeted therapy 8.1 (2023): 278.
Inquiry Basket